Multimodality therapy in inflammatory breast cancer: Is there a place for surgery?

Annals of Oncology

Volumn 11, Issue 9, 2000, Pages 1147-1153

  De Boer, R H ^a   Allum, W H ^b   Ebbs, S R ^c   Gui, G P H ^a   Johnston, S R D ^a   Sacks, N P M ^a   Walsh, G ^a   Ashley, S ^a   Smith, I E ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b EPSOM GENERAL HOSPITAL   (United Kingdom)

^c MAYDAY UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Breast; Cancer; Inflammatory; Multimodality; Surgery; Therapy

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; MITOMYCIN C; MITOXANTRONE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATORY BREAST CANCER; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0033784035     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008374931854     Document Type: Article

References (24)

1. Inflammatory breast cancer: A review
2. Management of inflammatory carcinoma of the breast: A combined modality approach
3. Diseases of the Breast, 2nd edition
4. The inoperability of inflammatory carcinoma of the breast
5. Inflammatory carcinoma of the breast
6. Inflammatory cancer of the breast: Analysis of 114 cases
7. Inflammatory breast carcinoma treated by radical radiotherapy
8. Primary chemotherapy in the treatment of inflammatory breast carcinoma: A study of 230 cases from the Institut Gustave-Roussy
9. Management of locally advanced carcinoma of the breast. II Inflammatory carcinoma
10. Inflammatory breast cancer
11. Treatment of locally advanced and inflammatory breast cancer
12. Two years of high-dose cyclophosphamide and 5-fluorouracil followed by surgery after three months for acute inflammatory breast carcinomas. A phase II study of 25 cases with a median follow-up of 35 months
13. Inflammatory carcinoma of the breast: Results of a combined-modality approach - M.D. Anderson Cancer Center experience
14. Inflammatory breast cancer
15. Surgery as part of a combined modality approach for inflammatory breast carcinoma
16. Multimodal treatment for inflammatory breast cancer
17. Multimodal treatment for locally advanced breast cancer
18. Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: A Cancer and Leukemia Group B study
19. Ten-year results utilizing chemotherapy as primary treatment in nonmetastatic rapidly progressing breast cancer
20. Treatment results, survival and prognostic factors in 109 inflammatory breast cancers: Univariate and multivariate analysis
21. The effect of systemic therapy on loco-regional control in locally advanced breast cancer
22. Treatment of inflammatory breast cancer with combination chemotherapy and nastectomy versus breast conservation
23. The Centre H. Bacquerel studies in inflammatory non metastatic breast cancer. Combined modality approach in 178 patients
24. Prognostic factors in inflammatory breast cancer and therapeutic implications